Guided Therapeutics Inc
OTC:GTHP

Watchlist Manager
Guided Therapeutics Inc Logo
Guided Therapeutics Inc
OTC:GTHP
Watchlist
Price: 0.3999 USD 33.26% Market Closed
Market Cap: $33.4m

Guided Therapeutics Inc
Investor Relations

Guided Therapeutics, Inc. engages in the development of medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Mark L. Faupel Ph.D.
CEO, President, COO, Acting CFO, Secretary & Director
No Bio Available

Contacts

Address
GEORGIA
Norcross
5835 Peachtree Cors E Ste B
Contacts
+17702428723.0
www.guidedinc.com